Deep Tech Startups

Kolmostar develops ultra low power GNSS SoC sensors for integration into devices.

2 investors

KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies. The company was founded around record-breaking integrase technology for improving gene editing vectors.

2 investors

Kremenak NanoTech (KNT) is a deep tech startup that develops patented and patent-pending nanoengineered material platform technologies and products, including Shredder, which uses material science to prevent microbial spoilage in commercial beverage production. Its R&D laboratory operates out of the University of Missouri Life Science Business Incubator.

2 investors

Kubos Semiconductors develops a Cubic GaN growth process to produce more efficient long-wavelength (green, amber, red) LEDs and full-colour microLED displays for applications including AR/VR headsets, TVs, general lighting, and visible light communications. Its technology is compatible with standard silicon CMOS substrates and MOCVD production tools, serving the LED and display device market.

2 investors

Kura develops AI-powered augmented reality glasses with features including a high-performance AR display, 6-DoF head tracking, SLAM environment mapping, eye-tracking, and gesture input. The hardware supports Unity, Unreal, and OpenXR development and includes a telepresence platform with robotics integration and AI app development toolkits.

2 investors

Kvasir Technologies develops biofuel technology that converts non-edible lignocellulosic biomass (such as straw, wood chips, and corn stover) into biocrude and drop-in bio-oil that can replace marine heavy fuel oil. It targets the renewable fuels sector for shipping, aviation, and heavy transport, with a focus on the EU green transition.

2 investors

Kymera International manufactures specialty materials and surface technologies, including metal powders, alloys, and advanced coatings, serving industrial customers across aerospace, automotive, electronics, and other sectors globally.

2 investors

Kynexis is a clinical-stage biotech developing KYN-5356, an oral small-molecule KAT-II inhibitor targeting the kynurenine pathway to improve cognition in neurological diseases. Its lead program is in a Phase 2 trial for cognitive impairment associated with schizophrenia (CIAS), with expansion planned into Alzheimer's disease.

2 investors

Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas. The company serves biopharma firms, clinical laboratories, and medical institutions through a network of clinical collaborators and research partners.

2 investors

Kyron.bio is a biotechnology company focused on developing therapeutic drugs, with an in-house R&D and laboratory operation.

2 investors

Lab 91 develops semiconductor processes and devices based on 2D materials such as MoS2. It focuses on advancing the semiconductor industry's adoption of 2D materials.

2 investors

LabelFlow develops image-labeling tools and a dataset marketplace to support the creation of computer vision and AI models at scale. It positions itself as a version-control-style platform for visual data.

2 investors

Labric builds data infrastructure for scientific research labs, automatically capturing instrument data, organizing it into custom databases, and enabling workflow automation and natural language analysis. It targets corporate R&D teams and research facilities that need clean, structured, AI-ready experimental data.

2 investors

Lactiga is a biotechnology company developing mucosal antibody therapies based on secretory IgA antibodies derived from human breastmilk. Its platform targets conditions such as chronic respiratory disorders, gut inflammation, and immune deficiencies through mucosal immunotherapy.

2 investors

Lanaco develops high-performance air filtration media made from New Zealand wool, applying natural fibre materials to industrial filters and breathable masks. Founded in 2011, the company focuses on sustainable, low-footprint filtration solutions.

2 investors

Lapto develops CPL (Capping Layer) materials with improved refractive index — both high- and low-refractive types — used to increase the efficiency of smartphone displays. The company supplies high-refractive CPL material to customers and is pursuing overseas licensing deals for its developed materials.

2 investors

LASE Innovation provides single-cell tracking and barcoding technology that captures time-dimension data to train AI/ML models for biological research. The company commercializes optical cell barcoding developed at Massachusetts General Hospital and MIT, enabling researchers to track millions of cells across time and conditions.

2 investors

Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.

2 investors

LATYS builds protocol-agnostic, non-reciprocal wireless relay antennas based on reconfigurable metasurfaces that operate below the MAC/physical layer. The hardware targets edge AI, autonomous systems, real-time inference, and sensor fusion workloads that require low-latency, deterministic wireless links.

2 investors

LayerLogic builds a portable graphene field-effect transistor (gFET) biosensor that detects Listeria monocytogenes in food-production environments, returning pass/fail results in under fifteen minutes without a lab. The single-use sensor is aimed at food producers for on-line microbial contamination testing, with a platform that can be re-tuned for other bacteria, viruses, and analytes.</parameter> <parameter name="hq_city">Göteborg

2 investors

LayerMetrics develops opto-photonic sensing and metrology technology for real-time optical measurement and process control. Its systems are aimed at advanced manufacturing of highly-integrated, 3D, nano-scale components.

2 investors

Learning Machine develops foundation models designed to continuously learn, adapt, and improve while performing tasks, without requiring dedicated training infrastructure or an in-house ML team. It targets businesses that want to build AI on their own proprietary data while keeping that data under their control.

2 investors

Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.

2 investors

Leica Microsystems manufactures optical microscopy instruments and fluorescence reagents for scientific research and diagnostics. The company serves laboratories, research institutions, and diagnostic facilities requiring advanced imaging and analytical equipment.

2 investors